Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07432009

Orthopedic Procedures and Postoperative Delirium in Older Adults in the Czech Republic

This multicenter, prospective, non-interventional observational study (ORTOPODCZ) investigates the association between preoperative cognitive impairment and postoperative delirium (POD) in older adults undergoing elective total hip arthroplasty in the Czech Republic. Postoperative delirium is a frequent and serious neurocognitive complication in senior surgical patients and is associated with increased morbidity, mortality, prolonged hospitalization, and impaired functional and cognitive outcomes. Despite international recommendations, routine preoperative cognitive screening remains insufficiently implemented.

The study evaluates the predictive value of the ALBA test, a brief cognitive screening tool, performed during the pre-anesthetic assessment. Postoperative delirium will be assessed using the validated CAM-ICU instrument for up to 72 hours after surgery. Secondary objectives include assessing the relationship between POD and frailty, polypharmacy, comorbidities, type of anesthesia, intraoperative hemodynamics, blood loss, vasoactive support, and postoperative complications.

Approximately 300-400 participants aged ≥65 years will be enrolled across seven centers. No additional procedures, biological sampling, or deviations from standard clinical care are required. Data will be collected in REDCap and analyzed according to a predefined statistical analysis plan. The study aims to provide robust evidence supporting the integration of cognitive screening into routine preoperative evaluation and to describe feasibility and implementation requirements for the ALBA test in clinical practice.

Recruiting

Interested in participating?

Request Info

Key information

About this study

Postoperative delirium (POD) is one of the most common perioperative neurocognitive disorders in older adults undergoing elective orthopedic procedures, particularly total hip arthroplasty. It is associated with adverse outcomes including increased morbidity, mortality, prolonged hospitalization, and long-term cognitive decline. Although international guidelines recommend routine preoperative cognitive assessment, its implementation in clinical practice remains limited.

This study builds on findings from a pilot project demonstrating the feasibility and potential predictive value of the ALBA test, a brief cognitive screening tool. The primary objective is to evaluate the association between ALBA test results (normal vs. pathological) and the occurrence of POD within 72 hours after surgery, diagnosed using the CAM-ICU instrument. Secondary objectives include assessing the relationship between POD and frailty (Clinical Frailty Scale), polypharmacy, comorbidities, preoperative anemia, type of anesthesia, intraoperative hemodynamic instability, blood loss, vasoactive medication use, reoperations, and postoperative complications.

The study is designed as a multicenter, prospective, non-interventional observational study conducted in seven hospitals in the Czech Republic. All participants will receive standard perioperative care without additional procedures or biological sampling. Cognitive screening (ALBA) will be performed during the pre-anesthetic assessment, and delirium monitoring (CAM-ICU) will be conducted at predefined intervals for up to 72 hours postoperatively. Data will be collected in REDCap and analyzed according to a predefined statistical analysis plan. The study also includes exploratory evaluation of the feasibility, acceptability, and implementation requirements of integrating the ALBA test into routine preoperative workflows.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 65 years
  • Elective total hip arthroplasty in general or regional anesthesia
  • ASA physical status I-III
  • Ability to understand and cooperate during testing; no severe sensory impairment (compensatory aids allowed)
  • Expected postoperative hospitalization in ICU, PACU, or standard ward

Exclusion criteria

  • Glasgow Coma Scale ≤ 14
  • Limited legal capacity
  • Active psychiatric disorder (e.g., psychotic disorder, bipolar disorder)
  • Active oncological disease
  • Chronic use of strong opioids
  • Premedication with anxiolytics or antipsychotics during preanesthetic evaluation
  • Acute reoperation within 3 months of primary surgery
  • Refusal to participate or withdrawal of consent

Treatment and study plan

Primary outcomes

  1. Incidence of postoperative delirium (POD)

    Time frame: 0-72 hours after surgery

    POD will be assessed using the CAM-ICU tool. Delirium is considered present if at least one CAM-ICU assessment is positive within the first 72 hours after surgery.

    The outcome will be expressed as the percentage of patients with POD.

Secondary outcomes

  1. Frailty score measured using the Clinical Frailty Scale (CFS)

    Time frame: Preoperative assessment

    Frailty will be assessed preoperatively using the Clinical Frailty Scale (CFS), which ranges from 1 to 9. Frailty is defined as CFS ≥ 4. The outcome will be expressed as the frailty score on the CFS scale.

    Frailty will be assessed preoperatively using the Clinical Frailty Scale (CFS), which ranges from 1 to 9. Frailty is defined as CFS ≥ 4. The outcome will be expressed as the frailty score on the CFS scale.Frailty will be assessed preoperatively using the Clinical Frailty Scale (CFS), which ranges from 1 to 9. Frailty is defined as CFS ≥ 4. The outcome will be expressed as the frailty score on the CFS scale.

  2. Number of comorbidities present preoperatively

    Time frame: Preoperative assessment

    Comorbidities will be recorded preoperatively, including cerebrovascular disease, cardiovascular disease, diabetes mellitus, chronic kidney disease, and others. The outcome will be expressed as the total number of comorbidities per patient.

  3. Presence of polypharmacy (>5 regular medications)

    Time frame: Preoperative medication list

    Polypharmacy will be assessed preoperatively and defined as the regular use of more than five medications. The outcome will be expressed as the percentage of patients meeting the definition of polypharmacy.

  4. Presence of preoperative anemia

    Time frame: Preoperative assessment

    Anemia will be assessed preoperatively according to local laboratory reference ranges. The outcome will be expressed as the percentage of patients who meet the definition of anemia.

    Anemia will be assessed preoperatively according to local laboratory reference ranges. The outcome will be expressed as the percentage of patients who meet the definition of anemia.

  5. Type of anesthesia used (general vs. regional)

    Time frame: 0-72 hours after surgery

    The type of anesthesia will be recorded as general anesthesia or regional anesthesia. The outcome will be expressed as the percentage of patients receiving each anesthesia type.

  6. Duration of urinary catheterization (hours)

    Time frame: 0-72 hours after surgery

    The duration of urinary catheterization (PMK) will be recorded daily from surgery until catheter removal. The outcome will be expressed as the total number of hours of urinary catheterization.

  7. Presence of reoperation within 72 hours after surgery

    Time frame: 0-72 hours after surgery

    Reoperation will be assessed as a binary variable (yes/no) within 72 hours after surgery. The outcome will be expressed as the percentage of patients who undergo reoperation.

  8. Intraoperative blood loss (milliliters)

    Time frame: Intraoperative period

    ntraoperative blood loss will be measured in milliliters as recorded by the surgical team. The outcome will be expressed as the total volume of blood loss during surgery.

  9. Use of vasoactive drugs during surgery

    Time frame: Intraoperative period

    The use of vasoactive drugs (e.g., noradrenaline, phenylephrine, ephedrine) will be assessed as a binary variable (yes/no) during the intraoperative period. The outcome will be expressed as the percentage of patients who receive vasoactive drugs.

Study contacts

Contact information is provided by the study sponsor or research team.

Klára Nekvindová, M.D, Ph.D.

CONTACT

[email protected]

+420577 551 111

Sponsors and collaborators

Lead sponsor

Tomas Bata Hospital, Czech Republic

Other

Collaborators

  • Czech Clinical Research Infrastructure Network

Registry information

Official study title

Orthopedic Procedures and Postoperative Delirium in the Czech Republic

Acronym: ORTOPODCZ

Important dates

Study start
2026
Primary completion
2029
Study completion
2030
First posted
Feb 25, 2026
Registry last updated
Jul 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.